Clinical trial
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute…
NCT00214630 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00214630 |
|---|---|
| Title | LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes |
| Official title | A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Coronary Syndromes |
| Intervention type | Drug |
| Interventions | rosuvastatin calcium, atorvastatin |
| Enrollment | 825 |
| Start date | Dec 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 19, 2010 |
| Countries | Costa Rica, El Salvador, Morocco, Panama, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: